Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019
Emma Bainbridge(University of California, San Francisco), Anne F. Luetkemeyer(University of California, San Francisco), David V. Glidden(University of California, San Francisco), Priscilla Y. Hsue(University of California, Los Angeles), Philip J. Norris(University of California, San Francisco), Kara L. Lynch(University of California, San Francisco), Jonathan H. Esensten(Memorial Sloan Kettering Cancer Center), Peter Chin‐Hong(University of California, San Francisco), Clara Di Germanio(National Institutes of Health), Monica Fung(University of California, San Francisco), Graham Simmons(University of California, San Francisco), Sarah B. Doernberg(Johns Hopkins University), Carolyn M. Hendrickson(University of California, San Francisco)
Cited by 3
Related Papers
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k
CD28 Costimulation: From Mechanism to Therapy
|Immunity|2016|936
Abnormal Brain Development in Newborns with Congenital Heart Disease
|New England Journal of Medicine|2007|851
Relationship between T Cell Activation and CD4 <sup>+</sup> T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
|The Journal of Infectious Diseases|2007|639